A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer
Clinical trial NCT05093907 · RECRUITING
Trial details
- NCT number
- NCT05093907
- Sponsor
- BeyondBio Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2026-11-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.